Senores Pharmaceuticals Seals U.S. Defense-Sector Gateway With Amerisyn JV

Senores Pharmaceuticals, Inc., the U.S. arm of Senores Pharmaceuticals Limited, executed the operating agreement on April 2, 2026. The partnership opens doors to high-entry-barrier government procurement markets, leveraging Senores’ manufacturing expertise and regulatory approvals across multiple geographies.  

Key Highlights  

• Formation of Amerisyn, LLC in the U.S.  
• Strategic entry into federal, veterans affairs, and defense supply contracts  
• Portfolio includes 46 ANDAs, 137 strengths, and robust R&D pipeline  
• Manufacturing footprint spans U.S., Baroda, and Ahmedabad with global regulatory approvals  
• Strong capabilities in APIs, injectables, and complex generics  

Sources: Senores Pharmaceuticals Limited Media Release